by Kevin Dooley, MD | Mar 18, 2026 | News and Information
A newly published study on pioglitazone in inclusion body myositis gives reason for cautious optimism, although the study was small and preliminary. The main goal was not to learn whether pioglitazone is effective in treating IBM, but to see if it could shift...